NASDAQ
No price data available for this timeframe.
Apogee Therapeutics, Inc. (APGE) reported revenue of $0 and net income of $-255.84M for FY 2025..
Financial data for APGE
0.00% YoY
40.46% YoY
27.88% YoY
Annual Income Statement for APGE
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Cost of Revenue | $1M | $0 | $0 | $0 |
| Gross Profit | -$1M | $0 | $0 | $0 |
| Operating Expenses | $284M | $217M | $93M | $31M |
| Operating Income | -$286M | -$217M | -$93M | -$31M |
| Net Income | -$256M | -$182M | -$84M | -$40M |
| EPS | $-4.22 | $-3.30 | $-1.66 | $-0.79 |
| EBITDA | -$284M | -$217M | -$75M | -$40M |